Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK …

…, N Prabhu, R Krishnamurthy, AG Richter, D Jyothish… - Pediatric …, 2020 - Springer
Children were relatively spared during COVID-19 pandemic. However, the recently reported
hyperinflammatory syndrome with overlapping features of Kawasaki disease and toxic …

Effect of amoxicillin dose and treatment duration on the need for antibiotic re-treatment in children with community-acquired pneumonia: the CAP-IT randomized …

…, R Wright, E Lee, U Ohia, S Hartshorn, D Jyothish… - Jama, 2021 - jamanetwork.com
Importance The optimal dose and duration of oral amoxicillin for children with community-acquired
pneumonia (CAP) are unclear. Objective To determine whether lower-dose …

Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): Prospective, national surveillance, United Kingdom and Ireland …

…, P Davis, T Bharucha, CE Pain, D Jyothish… - The Lancet Regional …, 2021 - thelancet.com
Background Paediatric Multisystem Inflammatory Syndrome temporally associated with
SARS-CoV-2 (PIMS-TS), first identified in April 2020, shares features of both Kawasaki disease (…

Obesity-Associated GNAS Mutations and the Melanocortin Pathway

…, I Barroso, J Mokrosiński, D Jyothish… - … England Journal of …, 2021 - Mass Medical Soc
Background GNAS encodes the Gα s (stimulatory G-protein alpha subunit) protein, which
mediates G protein–coupled receptor (GPCR) signaling. GNAS mutations cause …

[PDF][PDF] The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery

…, A Chikermane, P Dawson, S Hackett, D Jyothish… - Iscience, 2021 - cell.com
Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening disease
occurring several weeks after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

[HTML][HTML] Serology confirms SARS-CoV-2 infection in PCR-negative children presenting with paediatric inflammatory multi-system syndrome

…, DC Wraith, TV Veenith, MT Drayson, D Jyothish… - MedRxiv, 2020 - ncbi.nlm.nih.gov
Background During the COVID-19 outbreak, reports have surfaced of children who present
with features of a multisystem inflammatory syndrome with overlapping features of Kawasaki …

Vitamin D status of children with paediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2 (PIMS-TS …

…, BR Scholefield, S Uday, D Jyothish - British Journal of …, 2022 - cambridge.org
Coronavirus disease 2019 (COVID-19) has caused mild illness in children, until the emergence
of the novel hyperinflammatory condition paediatric inflammatory multisystem syndrome …

COVID-19: a UK children's hospital experience

…, SH Ali, J Kirk, P Nagakumar, D Jyothish - Hospital …, 2020 - publications.aap.org
OBJECTIVES: Reports from China relating to coronavirus disease (COVID-19) in children
indicate a milder disease course compared with adults. Although a few pediatric COVID-19 …

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a …

…, P Fleming, A Riordan, S Bandi, D Jyothish… - The Lancet Child & …, 2024 - thelancet.com
Background Paediatric multisystem inflammatory syndrome temporally associated with
SARS-CoV-2 (PIMS-TS), also known as multisystem inflammatory syndrome in children (MIS-C) …

Brittle asthma

JG Ayres, D Jyothish, T Ninan - Paediatric respiratory reviews, 2004 - Elsevier
Asthma is recognised as a heterogeneous disease and, within this heterogeneity, brittle asthma
is identified as a distinct phenotype. Two types of brittle asthma have been recognised in …